-
Sep 30, 2013, 10:00
by
Michael Croft
Med City News | Quintiles has launched a study to develop best practices in pre-screening for personalized cancer treatments. Focusing on colorectal cancer patients, the study will look at how pre-profiling and genomic sequencing data could support physician treatment decisions.
Full story
-
Sep 24, 2013, 13:00
by
Michael Croft
Vaccine News | Researchers at Duke Medicine developed a test that shows greater than 90% accuracy when distinguishing between viral and bacterial respiratory infections.
Full story
-
Sep 19, 2013, 10:00
by
Michael Croft
Clinical Informatics News Briefs | DreamIt Ventures is launching DreamIt Health Baltimore, a partnership with The Johns Hopkins University and BioHealth Innovation to recruit, invest in, and speed the growth and success of a select group of early-stage health IT companies.
Full story
-
Sep 18, 2013, 10:00
by
Michael Croft
Clinical Informatics News | Francois Torche, CEO of CluePoints, a statistical monitoring provider, has a front row vantage point on the ongoing industry-wide shift to risk-based monitoring (RBM). He sees RBM as critical to improving the quality of clinical trial data through the use of statistical methods that help define more effective on-site monitoring strategies.
Full story
-
Sep 13, 2013, 11:00
by
Michael Croft
Clinical Informatics News | Eli Lilly and Company has issued a public challenge to transform clinical trials from intimidating to patient-centered. With $75,000 in prize money available, the Clinical Trial Visualization Redesign Challenge is a call to creative, public innovators outside pharma to reconstruct communication and designs in patient-centered ways.
Full story
-
Sep 12, 2013, 11:00
by
Michael Croft
Clinical Informatics News Brief | DIA announced today that Barbara Lopez Kunz has begun leading the organization as global chief executive.
Full story
-
Sep 12, 2013, 10:00
by
Michael Croft
Clinical Informatics News | Guest Commentary | Following the fall of the Iron Curtain toward the end of the 1980´s, the region of Central and Eastern Europe including post-Soviet states was exposed to a growing demand among the pharmaceutical companies eager to conduct clinical trials. We have learned that this region—particularly the countries in the West of the region: Poland, Czech Republic, Hungary, Estonia, Slovakia and Slovenia—offers trial sponsors treatment standards and diagnostics technologies very close to the quality of Western European countries.
Full story
-
Sep 10, 2013, 07:00
by
Michael Croft
UT San Diego | Researchers from Harvard and Dana-Farber Cancer Institute announced they are starting an implanted melanoma vaccine into human clinical trials.
Full story
-
Sep 9, 2013, 13:00
by
Michael Croft
New York Times | The Albert and Mary Lasker Foundation awards were announced today. Winners include three scientists who helped deaf people to hear, two for their work in neurotransmission, and Bill and Melinda Gates for their public service work.
Full story
-
Sep 9, 2013, 10:00
by
Michael Croft
Nature | A HPV vaccine field trial in India is under fire from the Indian government because it didn't meet clinical trial guidelines. The field trial was funded by the Bill and Melinda Gates Foundation and measured how various distribution methods of HPV vaccines worked.
Full story
-
Sep 6, 2013, 11:00
by
Michael Croft
Technology Review | Jonathan Skinner considers how technology drives health care up, when it lowers the cost of everything else.
Full story
-
Sep 4, 2013, 07:00
by
Michael Croft
Clinical Informatics News | As drug discovery moves toward more personalized treatments, patient recruitment and patient-centered trial design is paramount. Well-enrolled, successful, cost-effective trials turn on the patients. An upcoming two-part event will delve into solutions for these issues.
Full story
-
Sep 4, 2013, 06:00
by
Michael Croft
Tampa Bay Business Journal | Moffitt Cancer Center has appointed Howard McLeod as the director of the new DeBartolo Family Personalized Medicine Institute.
Full story
-
Sep 3, 2013, 08:00
by
Michael Croft
Clinical Informatics News Brief | Bio-Optronics, developer of the Clinical Conductor Site CTMS, has launched the product at over 1,600 clinical research sites around the world, making it the most widely used clinical trial management system, the company said in a statement.
Full story
-
Aug 29, 2013, 12:00
by
Michael Croft
Clinical Informatics News | Electronic solutions have become a mainstay in clinical trials, yet one critical aspect, the informed consent process, has stubbornly remained paper-based. And that’s about to change.
Full story
-
Aug 28, 2013, 11:00
by
Michael Croft
Crain's Detroit Business | The Barbara Ann Karmanos Cancer Institute in Detroit has released its own cancer-specific iPhone and iPad applications. The apps are designed for physicians who are searching for clinical trials for their own patients.
Full story
-
Aug 28, 2013, 10:00
by
Michael Croft
Triangle Business Journal | CRO PPD has acquired Acurian--the clinical trial patient-enrollment firm.
Full story
-
Aug 26, 2013, 14:00
by
Michael Croft
Oncology Nurse Advisor | The blood brain barrier prevents many anticancer drugs from reaching areas of the brain to which cancer has spread, but cellular therapy in combination with genetic therapy show reduction of in metastatic brain tumor size.
Full story
-
Aug 26, 2013, 13:00
by
Michael Croft
OpenSource.com | Clinovo, a Clinical Research Organization (CRO) that partners with life science companies to streamline their clinical trials, believes healthcare needs open source.
Full story
-
Aug 23, 2013, 08:00
by
Michael Croft
Wall Street Journal | A hospital in Delaware is reaching out for patient feedback through social media. The children's hospital is surveying parents about their care preferences via a private social network.
Full story